Found 6 matching trials
Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
PHASE3The purpose of this study was to confirm efficacy and safety of osilodrosta...
Location
University of Colorado Endocrinology Clinical Trials Unit
A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension
PHASE2This study determined the maximum dose of LCI6999 with respect to effect on...
Location
Impact Clinical Trials
A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension
PHASE2This study assessed the blood pressure effect, safety and tolerability of L...
Location
Horizon Research Group, Inc
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
PHASE3The study aimed to confirm long-term efficacy and safety of LCI699 for the ...
Location
University of Colorado Hospital SC - LCI699C2301
A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
PHASE2This study was a proof-of-efficacy, dose finding study of LCI699 in partici...
Location
Novartis Pharmaceuticals
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
PHASE4Osilodrostat has proven to be a safe and efficacious treatment for patients...
Location
Multiple Locations